The Food Effect on the Pharmacokinetics of NVP-1402
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 12 Mar 2018
At a glance
- Drugs NVP 1402 (Primary)
- Indications CNS disorders
- Focus Pharmacokinetics
- Sponsors Navipharm
- 06 Mar 2018 Planned End Date changed from 28 Feb 2018 to 30 Apr 2018.
- 20 Dec 2017 Status changed from not yet recruiting to active, no longer recruiting.
- 17 Nov 2017 New trial record